Poststroke Cell Therapy of the Aged Brain
During aging, many neurodegenerative disorders are associated with reduced neurogenesis and a decline in the proliferation of stem/progenitor cells. The development of the stem cell (SC), the regenerative therapy field, gained tremendous expectations in the diseases that suffer from the lack of trea...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Neural Plasticity |
| Online Access: | http://dx.doi.org/10.1155/2015/839638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564205208731648 |
|---|---|
| author | Aurel Popa-Wagner Madalina Filfan Adriana Uzoni Pouya Pourgolafshan Ana-Maria Buga |
| author_facet | Aurel Popa-Wagner Madalina Filfan Adriana Uzoni Pouya Pourgolafshan Ana-Maria Buga |
| author_sort | Aurel Popa-Wagner |
| collection | DOAJ |
| description | During aging, many neurodegenerative disorders are associated with reduced neurogenesis and a decline in the proliferation of stem/progenitor cells. The development of the stem cell (SC), the regenerative therapy field, gained tremendous expectations in the diseases that suffer from the lack of treatment options. Stem cell based therapy is a promising approach to promote neuroregeneration after brain injury and can be potentiated when combined with supportive pharmacological drug treatment, especially in the aged. However, the mechanism of action for a particular grafted cell type, the optimal delivery route, doses, or time window of administration after lesion is still under debate. Today, it is proved that these protections are most likely due to modulatory mechanisms rather than the expected cell replacement. Our group proved that important differences appear in the aged brain compared with young one, that is, the accelerated progression of ischemic area, or the delayed initiation of neurological recovery. In this light, these age-related aspects should be carefully evaluated in the clinical translation of neurorestorative therapies. This review is focused on the current perspectives and suitable sources of stem cells (SCs), mechanisms of action, and the most efficient delivery routes in neurorestoration therapies in the poststroke aged environment. |
| format | Article |
| id | doaj-art-77a111969ca241168b7d9e653c994045 |
| institution | Kabale University |
| issn | 2090-5904 1687-5443 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Neural Plasticity |
| spelling | doaj-art-77a111969ca241168b7d9e653c9940452025-02-03T01:11:35ZengWileyNeural Plasticity2090-59041687-54432015-01-01201510.1155/2015/839638839638Poststroke Cell Therapy of the Aged BrainAurel Popa-Wagner0Madalina Filfan1Adriana Uzoni2Pouya Pourgolafshan3Ana-Maria Buga4Department of Functional Sciences, Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy of Craiova, Petru Rares Street 2, 200349 Craiova, RomaniaDepartment of Functional Sciences, Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy of Craiova, Petru Rares Street 2, 200349 Craiova, RomaniaUniversity Hospital Rostock, Gehlsheimer Street 20, 18147 Rostock, GermanyUniversity Hospital Rostock, Gehlsheimer Street 20, 18147 Rostock, GermanyDepartment of Functional Sciences, Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy of Craiova, Petru Rares Street 2, 200349 Craiova, RomaniaDuring aging, many neurodegenerative disorders are associated with reduced neurogenesis and a decline in the proliferation of stem/progenitor cells. The development of the stem cell (SC), the regenerative therapy field, gained tremendous expectations in the diseases that suffer from the lack of treatment options. Stem cell based therapy is a promising approach to promote neuroregeneration after brain injury and can be potentiated when combined with supportive pharmacological drug treatment, especially in the aged. However, the mechanism of action for a particular grafted cell type, the optimal delivery route, doses, or time window of administration after lesion is still under debate. Today, it is proved that these protections are most likely due to modulatory mechanisms rather than the expected cell replacement. Our group proved that important differences appear in the aged brain compared with young one, that is, the accelerated progression of ischemic area, or the delayed initiation of neurological recovery. In this light, these age-related aspects should be carefully evaluated in the clinical translation of neurorestorative therapies. This review is focused on the current perspectives and suitable sources of stem cells (SCs), mechanisms of action, and the most efficient delivery routes in neurorestoration therapies in the poststroke aged environment.http://dx.doi.org/10.1155/2015/839638 |
| spellingShingle | Aurel Popa-Wagner Madalina Filfan Adriana Uzoni Pouya Pourgolafshan Ana-Maria Buga Poststroke Cell Therapy of the Aged Brain Neural Plasticity |
| title | Poststroke Cell Therapy of the Aged Brain |
| title_full | Poststroke Cell Therapy of the Aged Brain |
| title_fullStr | Poststroke Cell Therapy of the Aged Brain |
| title_full_unstemmed | Poststroke Cell Therapy of the Aged Brain |
| title_short | Poststroke Cell Therapy of the Aged Brain |
| title_sort | poststroke cell therapy of the aged brain |
| url | http://dx.doi.org/10.1155/2015/839638 |
| work_keys_str_mv | AT aurelpopawagner poststrokecelltherapyoftheagedbrain AT madalinafilfan poststrokecelltherapyoftheagedbrain AT adrianauzoni poststrokecelltherapyoftheagedbrain AT pouyapourgolafshan poststrokecelltherapyoftheagedbrain AT anamariabuga poststrokecelltherapyoftheagedbrain |